William Tai-Wei Ho Buys $50K of In8bio Inc (INAB) — SEC Form 4, Aug 18, 2022

Open-Market Net Purchase · SEC Form 4
+$49,999

Equity position changed by +1.0%

Reporting Owner
William Tai-Wei Ho
CEO
TXN 2022-08-16 · FILED 2022-08-18
Equity Position 2.57M sh 2,544,929 → 2,571,244
Equity Change +1.0% shares held after vs before
Filing Lag 2 business days within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership

In8bio Inc

INAB CIK 0001740279
All In8bio Inc insider activity
Filing Date
2022-08-18
Report Date
2022-08-16
Accession No.
0001209191-22-046615
Accepted At
2022-08-18 20:15 UTC
Reporting Owner
Name Relationship
William Tai-Wei Ho CIK 0001830914
Director CEO
William Tai-Wei Ho at In8bio Inc Full insider history
Bought (12 mo) —
Sold (12 mo) —
More from this insider at In8bio Inc
2026-05-12 Award — View
2026-02-06 Award — View
2025-12-23 Award — View
2025-05-08 Award — View
2025-02-07 Award — View
All filings by this insider at In8bio Inc
Non-Derivative Securities Transactions
Title Date Type Shares Price Net Total Post-Txn Ownership
Common Stock 2022-08-16 P - Purchase 26,315 A $1.90 +$49,999 2,315,745 Direct
Non-Derivative Holdings
Title Shares Held Ownership
Common Stock 72,999 Indirect
Common Stock 73,000 Indirect
Common StockF1 36,500 Indirect
Common StockF1 36,500 Indirect
Common StockF1 36,500 Indirect
Footnotes (1)
F1
The shares are held by a relative of the Reporting Person. The Reporting Person has voting power pursuant to a voting proxy. Show more

Related filings at In8bio Inc

Institutional Holders
13F holders · Jun 30, 2026 20 institutional managers reporting a position
Largest by reported value
  1. Alyeska Investment Group, L.P. $1.33M
  2. Franklin Resources, Inc. $1.29M
  3. 683 Capital Management, Llc $1.02M
5%+ Holders · 13D/G 7 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at In8bio Inc
All In8bio Inc insider activity
GET /v1/forms/4/0001209191-22-046615 API docs
View Original SEC Filing